Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
NCT ID: NCT05921097
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2023-06-17
2024-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition to the direct comparison of the histamine-induced and the heating-induced axon-reflex flare response the study will also assess spatial acuity in the same cohort as a secondary aim. Spatial acuity is considered as a measure of the sensory systems ability to code spatial information regarding an external stimulus. To investigate the spatial acuity, the 2-point discrimination task (2PDT) is often used. Spatial acuity has been shown to be impaired in several chronic pain condition. Additionally, it has been shown that the 2PDT may be a useful tool to understand the sensory changes in diabetes\[8\].
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative Study
NCT01160887
Microvascular Dysfunction in Diabetic Peripheral Neuropathy
NCT05118217
Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study
NCT01512030
Thermal Biofeedback for the Treatment of Diabetic Neuropathy
NCT00858351
HTEMS Treatment of Diabetic Polyneuropathy
NCT04593992
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T1DM
People with type 1 diabetes
NC-Stat DPNCheck
NC-Stat DPNCheck
QST
QST
Biothesiometry
Biothesiometry
Histamin-induced axon-reflex flare response
Histamin-induced axon-reflex flare response
Local heating-induced axon-reflex flare response
Local heating-induced axon-reflex flare response
2-point discrimination tasks
2-point discrimination tasks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NC-Stat DPNCheck
NC-Stat DPNCheck
QST
QST
Biothesiometry
Biothesiometry
Histamin-induced axon-reflex flare response
Histamin-induced axon-reflex flare response
Local heating-induced axon-reflex flare response
Local heating-induced axon-reflex flare response
2-point discrimination tasks
2-point discrimination tasks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Symptoms of claudicatio intermittens
* Inability to do without antihistamine for 24h prior to examination
* Known neurological disease (e.g., multiple sclerosis)
* Severe skin diseases on either foot (e.g., fulminant pemphigoid)
* Previous or current alcohol or drug abuse
* Previous or current chemotherapy or current disseminated cancer
* Known cause of neuropathy other than diabetes
* Previous amputation on either foot
* Active diabetic foot ulcer on either foot
* Pregnancy
* Inability to participate or other condition thought to impact the results (evaluated by investigator)
* Asymmetrical neuropathy (i.e., previous accident with radiating pain)
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University
OTHER
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan Bovbjerg Røikjer
Postdoc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg University Hospital
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20230007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.